The claim that over-patenting hinders the development of new treatments is not supported by the evidence, says the US Biotechnology Industry Organization.

The US biotechnology industry has gone through more than three years of sustained IPO financings, but that news isn’t all rosy for the industry.

French biotech consultants Bionest Partners has a system for valuing loss-making biotech companies using information available on a company website.

UK Trade & Investment is hosting a delegation of Brazilian biotechnology executives this week, with a view to developing collaborations between the two countries.

Global acceptance of biotech crops increased in 2006, with acreage reaching 102 million hectares in 22 countries, according to a new report.

Danish biotech is on the rise and has outpaced its closest neighbour, Sweden, according to a study published last week.